---
title: "Adjuvant Advanced Cervical Cancer GY037 | Sutter Health"
description: "A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer"
url: "https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Research studies](https://www.sutterhealth.org/research/studies) /
4.  Adjuvant Advanced Cervical Cancer GY037

# Adjuvant Advanced Cervical Cancer GY037

A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

![J Alex Garcia-Young, M.D., DABR](https://dyn.mktgcdn.com/p/RIg-dZQzhveYLkMBvTvxcA7bC9jo7ddl-lwgbFCb57M/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100)

J Alex Garcia-Young, M.D., DABR

Principal investigator

[View profile](https://www.sutterhealth.org/research/investigators/j-alex-garcia-young-md-dabr-1078064877)

## Research topics

-   [Cervical Cancer](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Cervical+Cancer%5C%22%22)
-   [All Cancer](https://www.sutterhealth.org/research-search-results?query=%22%5C%22All+Cancer%5C%22%22)

## Related studies

[View all studies](https://www.sutterhealth.org/research/studies)

-   Research study
    
    ### [Bone Marrow Transplant Database](https://www.sutterhealth.org/research/studies/bone-marrow-transplant-1049141785)
    
    Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
    
-   Research study
    
    ### [Cancer Liquid Biopsy Monitoring Study](https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806)
    
    A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung cancer.
    
-   Research study
    
    ### [Ductal Carcinoma In Situ (DCIS) Registry Dana Farber](https://www.sutterhealth.org/research/studies/dana-farber-13-09-259-dcis-1049141920)
    
    Molecular Characterization of Breast Cancer with Duct Forming Features
    
-   Research study
    
    ### [Melanoma DECIDE](https://www.sutterhealth.org/research/studies/melanoma-castle-decide-1049141954)
    
    DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes
    
-   Research study
    
    ### [Melanoma Follow Up R3767-ONC-2466](https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020)
    
    Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613
    

[View all studies](https://www.sutterhealth.org/research/studies)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research studies","item":"https://www.sutterhealth.org/research/studies"},{"@type":"ListItem","position":4,"name":"Adjuvant Advanced Cervical Cancer GY037"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140#medicalwebpage","name":"Adjuvant Advanced Cervical Cancer GY037","description":"A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer","url":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140","inLanguage":"en-US","dateModified":"2026-10-02","publisher":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"medicalAudience":{"@type":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140#medicalobservationalstudy"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140#breadcrumblist"},"mentions":[{"@type":"Person","@id":"https://www.sutterhealth.org/find-provider/dr-jorge-a-garcia-young-1046236110#Person","name":"J Alex Garcia-Young, M.D., DABR","url":"https://www.sutterhealth.org/research/investigators/j-alex-garcia-young-md-dabr-1078064877","sameAs":"https://www.sutterhealth.org/find-provider/dr-jorge-a-garcia-young-1046236110"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalObservationalStudy","@id":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140#medicalobservationalstudy","name":"Adjuvant Advanced Cervical Cancer GY037","alternateName":"Adjuvant Advanced Cervical Cancer GY037","url":"https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140","description":"A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer","healthCondition":[{"@type":"MedicalCondition","name":"Cervical Cancer"},{"@type":"MedicalCondition","name":"All Cancer"}]}
```
